Notice: This company has been marked as potentially delisted and may not be actively trading. Acasti Pharma (ACST) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Acasti Pharma (NASDAQ:ACST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.51%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$1.25 MNumber OfInsiders Selling(Last 3 Years)0 Get ACST Insider Trade Alerts Want to know when executives and insiders are buying or selling Acasti Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACST Insider Buying and Selling by Quarter Ad Weiss RatingsThe War on Crypto is over …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … Acasti Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/25/2023Vimal KavuruDirectorBuy676,371$1.85$1,251,286.35 8/31/2023Donald OldsDirectorBuy381$2.05$781.05 (Data available from 1/1/2013 forward) ACST Insider Trading Activity - Frequently Asked Questions Who is on Acasti Pharma's Insider Roster? The list of insiders at Acasti Pharma includes Donald Olds, and Vimal Kavuru. Learn more on insiders at ACST. What percentage of Acasti Pharma stock is owned by insiders? 13.51% of Acasti Pharma stock is owned by insiders. Learn more on ACST's insider holdings. Which Acasti Pharma insiders have been buying company stock? The following insiders have purchased ACST shares in the last 24 months: Donald Olds ($781.05), and Vimal Kavuru ($1,251,286.35). How much insider buying is happening at Acasti Pharma? Insiders have purchased a total of 676,752 ACST shares in the last 24 months for a total of $1,252,067.40 bought. Acasti Pharma Key ExecutivesMr. Prashant Kohli (Age 52)CEO & Director Compensation: $358.41kMr. Robert J. DelAversano CPA (Age 52)Principal Financial & Accounting Officer Dr. R. Loch MacDonald M.D. (Age 62)Ph.D., Member of Scientific Advisory Board & Chief Medical Officer Mr. Amresh Kumar Ph.D. (Age 44)VP of Program Management Ms. Carrie D'Andrea (Age 52)VP of Clinical Operations More Insider Trading Tools from MarketBeat Related Companies Cardiff Oncology Insider Transactions Adverum Biotechnologies Insider Transactions Skye Bioscience Insider Transactions Immunic Insider Transactions Monopar Therapeutics Insider Transactions INmune Bio Insider Transactions Galectin Therapeutics Insider Transactions Context Therapeutics Insider Transactions MediciNova Insider Transactions Rani Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024? This page (NASDAQ:ACST) was last updated on 12/14/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredThe War on Crypto is over …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | Sponsored$1 Trillion About to Get Wiped Out Because of this Sneaky Fed Move?The Federal Reserve is sitting on almost $1 TRILLION in unrealized losses. The reason why is that the Fed i...Behind the Markets | SponsoredA British Madness in AmericaWarren Buffett offloaded nearly 70% of his Apple holdings. They know, as I do, The Big AI Die Up is coming....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acasti Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
